Abstract
The preparation and evaluation of the multisubstrate analogue 3 based on the 5,8,10-trideazafolate core for GAR and AICAR Tfase inhibition is detailed.
Original language | English (US) |
---|---|
Pages (from-to) | 1853-1857 |
Number of pages | 5 |
Journal | Bioorganic and Medicinal Chemistry |
Volume | 5 |
Issue number | 9 |
DOIs | |
State | Published - Sep 1997 |
All Science Journal Classification (ASJC) codes
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmaceutical Science
- Drug Discovery
- Clinical Biochemistry
- Organic Chemistry